Loading...
XTAI1720
Market cap336mUSD
Dec 23, Last price  
61.50TWD
1D
0.65%
1Q
-4.95%
Jan 2017
88.65%
Name

Standard Chem & Pharm Co Ltd

Chart & Performance

D1W1MN
XTAI:1720 chart
P/E
13.16
P/S
1.76
EPS
4.67
Div Yield, %
4.07%
Shrs. gr., 5y
—
Rev. gr., 5y
11.80%
Revenues
6.24b
+6.64%
1,924,414,0002,011,721,0002,182,198,0002,284,616,0002,894,482,0003,332,008,0003,373,811,0003,053,983,0003,295,656,0003,321,366,0003,673,801,0003,848,684,0003,573,093,0003,937,129,0004,305,400,0004,604,082,0005,851,368,0006,239,768,000
Net income
835m
-27.63%
323,443,000267,715,000274,597,000293,463,000210,053,000246,748,000271,426,000298,386,000374,235,000347,894,000340,216,000363,286,000374,359,000376,482,000524,172,000706,734,0001,153,620,000834,886,000
CFO
1.34b
+8.85%
358,745,000323,595,000719,169,000634,227,000272,474,000405,494,000402,246,000427,259,000582,305,000650,865,000305,376,000708,738,000484,935,000637,939,000922,580,000827,034,0001,227,834,0001,336,523,000
Dividend
Aug 01, 20242.7 TWD/sh
Earnings
Mar 14, 2025

Profile

Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.
URL
https://www.standard.com.tw/
IPO date
Dec 12, 1995
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
6,239,768
6.64%
5,851,368
27.09%
4,604,082
6.94%
Cost of revenue
4,989,283
4,715,135
3,726,469
Unusual Expense (Income)
NOPBT
1,250,485
1,136,233
877,613
NOPBT Margin
20.04%
19.42%
19.06%
Operating Taxes
279,938
246,313
176,948
Tax Rate
22.39%
21.68%
20.16%
NOPAT
970,547
889,920
700,665
Net income
834,886
-27.63%
1,153,620
63.23%
706,734
34.83%
Dividends
(446,740)
(446,740)
(321,653)
Dividend yield
3.79%
4.06%
4.17%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
883,193
1,829,066
1,680,280
Long-term debt
690,579
676,597
549,625
Deferred revenue
205,314
Other long-term liabilities
235,814
149,464
532
Net debt
(1,669,493)
(598,169)
(1,103,826)
Cash flow
Cash from operating activities
1,336,523
1,227,834
827,034
CAPEX
(625,696)
(1,197,542)
(217,916)
Cash from investing activities
(653,125)
(1,080,831)
819,123
Cash from financing activities
(957,365)
(465,444)
(117,541)
FCF
769,849
(304,781)
(482,604)
Balance
Cash
2,275,533
2,599,039
2,989,234
Long term investments
967,732
504,793
344,497
Excess cash
2,931,277
2,811,264
3,103,527
Stockholders' equity
8,908,165
7,215,530
6,595,543
Invested Capital
6,769,760
6,799,525
5,707,784
ROIC
14.31%
14.23%
13.65%
ROCE
12.89%
11.72%
9.86%
EV
Common stock shares outstanding
178,890
178,885
178,918
Price
65.90
7.15%
61.50
42.69%
43.10
14.32%
Market cap
11,788,851
7.16%
11,001,428
42.67%
7,711,366
14.34%
EV
12,957,679
13,085,686
9,065,278
EBITDA
1,598,258
1,434,838
1,098,677
EV/EBITDA
8.11
9.12
8.25
Interest
25,793
18,775
7,250
Interest/NOPBT
2.06%
1.65%
0.83%